Maintenance  	Maintenance  	 NN	O
of  	of  	 IN	O
autoantibody  	autoantibody  	 JJ	B-NP
production  	production  	 NN	I-NP
in  	in  	 IN	O
pristane-induced  	pristane-induced  	 JJ	B-NP
murine  	murine  	 NNS	I-NP
lupus  	lupus  	 VBP	O
Pristane-treated  	Pristane-treated  	 JJ	B-NP
mice  	mice  	 NNS	I-NP
chronically  	chronically  	 RB	O
produce  	produce  	 VB	O
high  	high  	 JJ	O
levels  	levels  	 NNS	O
of  	of  	 IN	O
anti-ribonucleoprotein 	anti-ribonucleoprotein 	 NNP	B-NP
/ 	/ 	 NNP	I-NP
Smith  	Smith  	 NNP	I-NP
( 	( 	 -LRB-	O
anti-Sm 	anti-Sm 	 NNP	B-NP
/ 	/ 	 NNP	I-NP
RNP 	RNP 	 NNP	I-NP
)  	)  	 -RRB-	O
and  	and  	 CC	O
other  	other  	 JJ	O
lupus  	lupus  	 JJ	B-NP
autoantibodies 	autoantibodies 	 NN	I-NP
.  	.  	 .	O
The  	The  	 DT	O
present  	present  	 JJ	O
study  	study  	 NN	O
addressed  	addressed  	 VBD	O
how  	how  	 WRB	O
these  	these  	 DT	O
autoantibody  	autoantibody  	 JJ	B-NP
levels  	levels  	 NNS	I-NP
are  	are  	 VBP	O
maintained  	maintained  	 VBN	O
over  	over  	 IN	O
time 	time 	 NN	O
.  	.  	 .	O
Lupus  	Lupus  	 NNP	B-NP
was  	was  	 VBD	O
induced  	induced  	 VBN	O
in  	in  	 IN	O
BALB 	BALB 	 NNP	B-NP
/ 	/ 	 NNP	I-NP
c  	c  	 SYM	I-NP
mice  	mice  	 FW	I-NP
using  	using  	 FW	O
pristane 	pristane 	 FW	B-NP
.  	.  	 .	O
Naïve  	Naïve  	 NNP	B-NP
B  	B  	 NNP	I-NP
cells 	cells 	 NNS	I-NP
,  	,  	 ,	O
switched  	switched  	 VBD	B-NP
memory  	memory  	 NN	I-NP
B  	B  	 NN	I-NP
cells 	cells 	 NNS	I-NP
,  	,  	 ,	O
switched  	switched  	 VBD	B-NP
plasmablasts 	plasmablasts 	 CD	I-NP
,  	,  	 ,	O
and  	and  	 CC	O
plasma  	plasma  	 JJ	O
cells  	cells  	 NNS	O
were  	were  	 VBD	O
flow-sorted  	flow-sorted  	 JJ	O
and  	and  	 CC	O
total  	total  	 JJ	B-NP
IgG  	IgG  	 JJ	I-NP
and  	and  	 CC	O
anti-U1A  	anti-U1A  	 NNP	O
( 	( 	 -LRB-	O
RNP 	RNP 	 NNP	B-NP
)  	)  	 -RRB-	O
autoantibodies  	autoantibodies  	 NN	B-NP
were  	were  	 VBD	O
determined  	determined  	 VBN	O
with  	with  	 IN	O
ELISA 	ELISA 	 NNP	B-NP
.  	.  	 .	O
B  	B  	 NNP	B-NP
cells  	cells  	 NNS	I-NP
with  	with  	 IN	O
a  	a  	 DT	O
switched  	switched  	 JJ	O
memory-like  	memory-like  	 NN	B-NP
( 	( 	 -LRB-	I-NP
CD19 	CD19 	 NNP	I-NP
( 	( 	 -LRB-	I-NP
+ 	+ 	 NNP	I-NP
) 	) 	 -RRB-	I-NP
CD138 	CD138 	 NNP	I-NP
( 	( 	 -LRB-	I-NP
- 	- 	 NNP	I-NP
) 	) 	 -RRB-	I-NP
IgM 	IgM 	 NNP	I-NP
( 	( 	 -LRB-	I-NP
- 	- 	 NNP	I-NP
) 	) 	 -RRB-	I-NP
IgD 	IgD 	 NNP	I-NP
( 	( 	 -LRB-	I-NP
- 	- 	 NNP	I-NP
) 	) 	 -RRB-	I-NP
)  	)  	 -RRB-	O
( 	( 	 -LRB-	O
sMB 	sMB 	 NNP	B-NP
)  	)  	 -RRB-	O
phenotype  	phenotype  	 NN	B-NP
were  	were  	 VBD	O
increased  	increased  	 VBN	O
in  	in  	 IN	O
pristane-treated  	pristane-treated  	 JJ	B-NP
mice  	mice  	 NNS	I-NP
and  	and  	 CC	O
expressed  	expressed  	 VBD	O
higher  	higher  	 JJR	O
levels  	levels  	 NNS	O
of  	of  	 IN	O
Toll  	Toll  	 NNP	B-NP
like  	like  	 IN	I-NP
receptor  	receptor  	 CD	I-NP
7  	7  	 CD	I-NP
( 	( 	 -LRB-	O
Tlr7 	Tlr7 	 NNP	B-NP
)  	)  	 -RRB-	O
than  	than  	 IN	O
cells  	cells  	 NNS	O
with  	with  	 IN	O
this  	this  	 DT	O
phenotype  	phenotype  	 NN	B-NP
from  	from  	 IN	O
untreated  	untreated  	 JJ	O
mice 	mice 	 NNS	O
.  	.  	 .	O
Flow-sorted  	Flow-sorted  	 JJ	O
sMB  	sMB  	 JJ	B-NP
cells  	cells  	 NNS	I-NP
from  	from  	 IN	O
pristane-treated  	pristane-treated  	 JJ	B-NP
mice  	mice  	 NNS	I-NP
did  	did  	 VBD	O
not  	not  	 RB	O
secrete  	secrete  	 JJ	O
IgG  	IgG  	 JJ	O
spontaneously 	spontaneously 	 NN	O
,  	,  	 ,	O
but  	but  	 CC	O
were  	were  	 VBD	O
hyper-responsive  	hyper-responsive  	 JJ	B-NP
to  	to  	 TO	O
both  	both  	 DT	O
synthetic  	synthetic  	 JJ	B-NP
( 	( 	 -LRB-	O
R848 	R848 	 NNP	B-NP
)  	)  	 -RRB-	O
and  	and  	 CC	O
natural  	natural  	 JJ	O
( 	( 	 -LRB-	O
apoptotic  	apoptotic  	 JJ	B-NP
cells 	cells 	 NNS	I-NP
)  	)  	 -RRB-	O
TLR7  	TLR7  	 CD	B-NP
ligands 	ligands 	 NN	I-NP
,  	,  	 ,	O
resulting  	resulting  	 VBG	O
in  	in  	 IN	O
increased  	increased  	 JJ	O
IgG  	IgG  	 JJ	B-NP
production  	production  	 NN	I-NP
in  	in  	 IN	O
vitro 	vitro 	 NN	B-NP
.  	.  	 .	O
The  	The  	 DT	O
flow-sorted  	flow-sorted  	 JJ	O
sMB  	sMB  	 JJ	B-NP
cells  	cells  	 NNS	I-NP
also  	also  	 RB	O
could  	could  	 MD	O
be  	be  	 VB	O
driven  	driven  	 VBN	O
by  	by  	 IN	O
R848  	R848  	 CD	B-NP
to  	to  	 TO	O
produce  	produce  	 VB	O
IgG  	IgG  	 JJ	O
anti-U1A  	anti-U1A  	 CD	O
autoantibodies 	autoantibodies 	 NNS	O
.  	.  	 .	O
Production  	Production  	 NN	O
of  	of  	 IN	O
IgG  	IgG  	 NNP	B-NP
was  	was  	 VBD	O
strongly  	strongly  	 RB	O
inhibited  	inhibited  	 VBN	O
by  	by  	 IN	O
both  	both  	 DT	O
JSH-23  	JSH-23  	 NNP	B-NP
and  	and  	 CC	O
SB203580 	SB203580 	 NNP	O
,  	,  	 ,	O
suggesting  	suggesting  	 VBG	O
that  	that  	 IN	O
the  	the  	 DT	O
canonical  	canonical  	 JJ	B-NP
NFκB  	NFκB  	 JJ	I-NP
and  	and  	 CC	O
p38  	p38  	 NNP	B-NP
MAPK  	MAPK  	 NNP	I-NP
pathways 	pathways 	 NN	I-NP
,  	,  	 ,	O
respectively 	respectively 	 RB	O
,  	,  	 ,	O
contribute  	contribute  	 VBP	O
to  	to  	 TO	O
the  	the  	 DT	O
TLR7  	TLR7  	 JJ	B-NP
ligand  	ligand  	 JJ	I-NP
hyper-responsiveness  	hyper-responsiveness  	 NN	I-NP
of  	of  	 IN	O
sMB  	sMB  	 JJ	O
from  	from  	 IN	O
pristane-treated  	pristane-treated  	 JJ	B-NP
mice 	mice 	 NNS	I-NP
.  	.  	 .	O
The  	The  	 DT	O
switched  	switched  	 JJ	O
memory  	memory  	 NN	B-NP
B  	B  	 NN	I-NP
cell  	cell  	 NN	I-NP
subset  	subset  	 NN	I-NP
from  	from  	 IN	O
pristane-treated  	pristane-treated  	 JJ	B-NP
mice  	mice  	 NNS	I-NP
is  	is  	 VBZ	O
expanded  	expanded  	 VBN	O
and  	and  	 CC	O
shows  	shows  	 VBZ	O
an  	an  	 DT	O
increased  	increased  	 JJ	O
propensity  	propensity  	 NN	O
to  	to  	 TO	O
undergo  	undergo  	 VB	O
terminal  	terminal  	 NN	O
( 	( 	 -LRB-	O
plasma  	plasma  	 JJ	O
cell 	cell 	 NN	O
)  	)  	 -RRB-	O
differentiation  	differentiation  	 NN	B-NP
in  	in  	 IN	O
response  	response  	 NN	O
to  	to  	 TO	O
synthetic  	synthetic  	 JJ	B-NP
and  	and  	 CC	O
natural  	natural  	 JJ	O
TLR7  	TLR7  	 CD	B-NP
ligands 	ligands 	 NNS	I-NP
.  	.  	 .	O
The  	The  	 DT	O
data  	data  	 NNS	O
suggest  	suggest  	 VBP	O
that  	that  	 IN	O
the  	the  	 DT	O
decreased  	decreased  	 JJ	O
clearance  	clearance  	 NN	O
of  	of  	 IN	O
apoptotic  	apoptotic  	 JJ	B-NP
cells  	cells  	 NNS	I-NP
characteristic  	characteristic  	 NN	O
of  	of  	 IN	O
pristane-treated  	pristane-treated  	 JJ	B-NP
mice  	mice  	 NNS	I-NP
might  	might  	 MD	O
help  	help  	 VB	O
maintain  	maintain  	 VB	O
high  	high  	 JJ	O
serum  	serum  	 JJ	B-NP
levels  	levels  	 NNS	I-NP
of  	of  	 IN	I-NP
anti-RNP 	anti-RNP 	 NNP	I-NP
/ 	/ 	 NNP	I-NP
Sm  	Sm  	 NNP	I-NP
autoantibodies 	autoantibodies 	 NN	I-NP
.  	.  	 .	O
